Has Fadi Alhatem, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,721 in general payments to Fadi Alhatem, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fadi Alhatem, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fadi Alhatem, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fadi Alhatem, MD

Pain Medicine · Beverly Hills, CANPI 1467672485

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Medtronic at 44.0% of the total. Reporting peaked in 2022 at $825 and has fallen 68.3% since, to $261 in 2025.

$2,721in general payments, 2019–2025

Across 76 payments — averaging $35.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$1K
Saluda Medical Americas, Inc.$378
Nevro Corp.$333
Pfizer$172
Amgen$168
Abbott$120
plus $353 from 10 others

What the payments were for

Travel & lodging$873%
Food & beverage$2,63497%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	34	$1,198
Saluda Medical Americas, Inc.	8	$378
Nevro Corp.	5	$333
Pfizer	4	$172
Amgen	3	$168
Abbott	5	$120
Nalu Medical, Inc.	4	$93
Tersera Therapeutics LLC	2	$52
Collegium Pharmaceutical, Inc.	3	$47
Scilex Pharmaceuticals Inc.	2	$45
Boston Scientific	1	$27
Biotronik NRO, Inc.	1	$23
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$20
Kowa Pharmaceuticals America, Inc.	1	$19
Valinor Pharma, LLC	1	$14
Biodelivery Sciences International, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,721 in reported general payments places this provider in the 55th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$112,906

Medicare patients

238

Services billed

2,310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	681	$21,512
Lidocaine	133	$13,670
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	417	$13,103
OxycontinOxycodone Hcl	27	$10,899
MovantikNaloxegol Oxalate	11	$6,764
Oxycodone Hcl	262	$5,363
Fentanyl	42	$3,623
Gabapentin	271	$3,475
Morphine Sulfate ErMorphine Sulfate	82	$2,912
Pregabalin	145	$2,636
Morphine Sulfate	79	$2,504
Naloxone Hcl	40	$2,121
Cyclobenzaprine Hcl	159	$1,584
Tramadol Hcl	154	$1,286
Methocarbamol	87	$1,268

Paid to pharmacies, not to this prescriber.

Other pain medicine in Beverly Hills

Jason PopeSanta Rosa$2.1M
Ramana NaiduLarkspur$1.4M
Foead GeulaStudio City$1.3M
Krishnan ChakravarthyTemecula$1.3M
Kasra AmirdelfanWalnut Creek$783K
Eric GrigsbyNapa$499K
Jacqueline WeisbeinNapa$494K
Gerald SacksSanta Monica$389K
Samir ShethRoseville$356K
Einar OttestadStanford$352K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →